Hepatitis B Vaccine Refusal in the Newborn Period

Area of Science:

• Pediatrics
• Immunology
• Public Health

Background:

• Perinatal hepatitis B (HepB) infection leads to chronic illness in up to 90% of infants.
• The HepB vaccine birth dose is essential for preventing perinatal transmission.
• Recent 2018 guidelines updated HepB vaccine administration timelines for various maternal HepB statuses.

Purpose of the Study:

• To review the 2018 Advisory Committee on Immunization Practices guidelines for the HepB vaccine birth dose.
• To examine the impact of these guidelines on vaccine administration rates.
• To identify factors influencing the uptake of the HepB vaccine birth dose.

Main Methods:

• Analysis of the 2018 Advisory Committee on Immunization Practices recommendations.
• Review of data on HepB vaccine birth dose administration rates.
• Discussion of provider and institutional influences on vaccine uptake.

Main Results:

• Despite updated guidelines, up to 25% of infants do not receive the HepB vaccine at birth.
• Individual provider commitment is vital for vaccine administration.
• Institutional policies significantly impact the appropriate administration of the HepB vaccine.

Conclusions:

• Ensuring timely HepB vaccine birth dose administration requires both provider diligence and supportive institutional policies.
• Addressing the gap in HepB vaccine birth dose coverage is critical for preventing chronic HepB infection in infants.
• Continued efforts are needed to improve adherence to HepB vaccination guidelines.